As climate change intensifies harmful algal blooms worldwide, an international team led by Hiroshima University has developed a hybrid modeling approach that combines algal movement simulations, AI, and long-term monitoring data to sharpen forecasts of these bloom events—linked to environmental damage, mass fish die-offs, economic losses, and risks to human health.

NCCN announces the selection of Nancy L. Lewis, MD, MBS, FACP, as new Chief Scientific Officer (CSO).

The Chinese Society of Endocrinology has recently released an evidence-based guideline on physical activity and exercise therapy for Chinese adult patients with type 2 diabetes (T2D). The guideline consolidates the latest scientific evidence and expert consensus to address the critical role of physical activity and exercise in diabetes prevention and management, which is available online in the Journal of Sport and Health Science on January 12, 2026.

A domestically produced Escherichia coli (E. coli)-based 9-valent HPV 6/11/16/18/31/33/45/52/58 vaccine has been successfully developed and approved in China. A randomized bridging clinical trial demonstrated that this 9-valent HPV vaccine was well tolerated and highly immunogenic in healthy adolescents aged 9–17 years, with immune responses elicited by a two-dose regimen being non-inferior to those induced by a three-dose regimen in young women. These findings support the use of a two-dose immunization schedule in adolescents and provide evidence for optimizing HPV vaccination strategies.